In a one-day symposium, hosted by the law school’s Center for Intellectual Property & Entrepreneurship and Business, Entrepreneurship, and Tax Law Review, a distinguished group of panelists will consider both substantive principles for regulating effectively in particular areas (e.g., financial markets, telecommunications, prescription drugs, network technologies) and broader procedural questions about how regulations should be crafted. What substantive principles should guide…
Tag: Innovation policy ⋅ Page 1
Professor Lietzan Speaks at Conference about New Uses of Established Drugs
On February 8, Professor Erika Lietzan spoke at the conference, “Clinical Innovation: Fair and Effective Incentives for New Uses of Established Drugs,” convened in Washington, DC, by University College London (UCL) and the Georgetown University Law Center (GULC). This invitation-only conference gathered more than 40 experienced thought leaders — including scientists, industry executives, lawyers, law professors, business professors, judges, retired judges, and regulators, most with several decades of…